These results suggested that the loss of ASPP2 promoted DEN-induced hepatocarcinogenesis in mice, which might be caused by the activation of the NF-κB pathway and by the regulation of the expression of inflammatory factors and tumor-related genes in the livers. This evidence concerns the gene TP53BP2 and neoplasm.